# Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

> **NCT04411693** · PHASE4 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 23 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Dexamethasone implant
- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT04411693
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-10
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04411693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04411693, "Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04411693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*